Evidence map›Paper›PMID 35312728›Full record

ArticlePloS one2022

Variation in CFTR-dependent 'β-sweating' among healthy adults.

Lesje DeRose, Jeeyeon Kim, Miesha Farahmand, Meagan Y Shinbashi, Nam Soo Joo, Jeffrey J Wine

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lesje DeRoseCystic Fibrosis Research Laboratory, Stanford University, Stanford, California, United States of America.
Jeeyeon KimCystic Fibrosis Research Laboratory, Stanford University, Stanford, California, United States of America.
Miesha FarahmandCystic Fibrosis Research Laboratory, Stanford University, Stanford, California, United States of America.
Meagan Y ShinbashiCystic Fibrosis Research Laboratory, Stanford University, Stanford, California, United States of America.
Nam Soo JooCystic Fibrosis Research Laboratory, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-0510-6862
Jeffrey J WineCystic Fibrosis Research Laboratory, Stanford University, Stanford, California, United States of America.
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic disease cystic fibrosis (CF) results when mutations in the gene for the anion channel CFTR reduce CFTR's activity below a critical level. CFTR activity = N·PO·γ (number of channels x open probability x channel conductance). Small molecules are now available that partially restore CFTR function with dramatic improvements in health of CF subjects. Continued evaluation of these and other compounds in development will be aided by accurate assessments of CFTR function. However, measuring CFTR activity in vivo is challenging and estimates vary widely. The most accurate known measure of CFTR activity in vivo is the 'β/M' ratio of sweat rates, which is produced by stimulation with a β-adrenergic agonist cocktail referenced to the same individual's methacholine-stimulated sweat rate. The most meaningful metric of CFTR activity is to express it as a percent of normal function, so it is critical to establish β/M carefully in a population of healthy control subjects. Here, we analyze β/M from a sample of 50 healthy adults in which sweat rates to cholinergic and β-adrenergic agonists were measured repeatedly (3 times) in multiple, (~50) identified sweat glands from each individual (giving ~20,000 measurements). The results show an approximately 7-fold range, 26-187% of the WT average set to 100%. These provide a benchmark against which other measures of CFTR activity can be compared. Factors contributing to β/M variation in healthy controls are discussed.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorAdultHumansSweatSweat GlandsSweatingCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID35312728
PMCPMC8936459
OpenAlexW4220782253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.